DK105699C - Fremgangsmåde til fremstilling af N,N'-bis-(α-pyridylethyl)-alkylendiaminer eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf. - Google Patents

Fremgangsmåde til fremstilling af N,N'-bis-(α-pyridylethyl)-alkylendiaminer eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.

Info

Publication number
DK105699C
DK105699C DK117361AA DK117361A DK105699C DK 105699 C DK105699 C DK 105699C DK 117361A A DK117361A A DK 117361AA DK 117361 A DK117361 A DK 117361A DK 105699 C DK105699 C DK 105699C
Authority
DK
Denmark
Prior art keywords
pyridylethyl
alkylenediamines
bis
preparation
quaternary ammonium
Prior art date
Application number
DK117361AA
Other languages
English (en)
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of DK105699C publication Critical patent/DK105699C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22BPRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B3/00Extraction of metal compounds from ores or concentrates by wet processes
    • C22B3/20Treatment or purification of solutions, e.g. obtained by leaching
    • C22B3/26Treatment or purification of solutions, e.g. obtained by leaching by liquid-liquid extraction using organic compounds
    • C22B3/36Heterocyclic compounds
    • C22B3/362Heterocyclic compounds of a single type
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P10/00Technologies related to metal processing
    • Y02P10/20Recycling

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Metallurgy (AREA)
  • Environmental & Geological Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Materials Engineering (AREA)
  • Geology (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK117361AA 1960-03-21 1961-03-20 Fremgangsmåde til fremstilling af N,N'-bis-(α-pyridylethyl)-alkylendiaminer eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf. DK105699C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1619960A 1960-03-21 1960-03-21

Publications (1)

Publication Number Publication Date
DK105699C true DK105699C (da) 1966-10-31

Family

ID=21775901

Family Applications (1)

Application Number Title Priority Date Filing Date
DK117361AA DK105699C (da) 1960-03-21 1961-03-20 Fremgangsmåde til fremstilling af N,N'-bis-(α-pyridylethyl)-alkylendiaminer eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.

Country Status (3)

Country Link
DK (1) DK105699C (da)
ES (1) ES265020A1 (da)
GB (1) GB969510A (da)

Also Published As

Publication number Publication date
ES265020A1 (es) 1961-08-16
GB969510A (en) 1964-09-09

Similar Documents

Publication Publication Date Title
DK113854B (da) Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf.
DK115999B (da) Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf.
DK105032C (da) Fremgangsmåde til fremstilling af 4-oxo-1,2,3,4-tetrahydrochinalzoliner eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK104746C (da) Fremgangsmåde til fremstilling af 2-α-aminoalkanoylamido-benzophenon-forbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK105699C (da) Fremgangsmåde til fremstilling af N,N'-bis-(α-pyridylethyl)-alkylendiaminer eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK104299C (da) Fremgangsmåde til fremstilling af tertiæraminoalkylidensubstituerede dibenzocycloheptadien-, dibenzocycloheptatrien- eller thioxanthenforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK98244C (da) Fremgangsmåde til fremstilling af 5,10,11,12-tetrahydro-dibenz(b,g)-azocinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK98245C (da) Fremgangsmåde til fremstilling af 5,10,11,12-tetrahydro-dibenz(b,g)-azocinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK98372C (da) Fremgangsmåde til fremstilling af 5,10,11,12-tetrahydro-dibenz(b,g)azocinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK95640C (da) Fremgangsmåde til fremstilling af phentiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK98890C (da) Fremgangsmåde til fremstilling af 3-nitro-phenthiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK98299C (da) Fremgangsmåde til fremstilling af 3-nitro-phenthiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK96358C (da) Fremgangsmåde til fremstilling af 10-dialkylaminoalkyl-phenthiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK100171C (da) Fremgangsmåde til fremstilling af basisk substituerede 5-dibenzothiazepin-eller 5-dibenzodiazepinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK100053C (da) Fremgangsmåde til fremstilling af basisk substituerede 5-dibenzothiazepin-eller 5-dibenzodiazepinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK99308C (da) Fremgangsmåde til fremstilling af dihydrodibenzo-(b,e)(1,4)-thiazepinforbindelser eller syreadditionssalte eller kvaternære ammoniumbindelser deraf.
DK98757C (da) Fremgangsmåde til fremstilling af dihydrodibenzo-(b,e)(1,4)-thiazepinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK101240C (da) Fremgangsmåde til fremstilling af 1,1-dicyclohexyl-2-(2-piperidyl-ethylen eller syreadditionssalte heraf.
DK103666C (da) Fremgangsmåde til fremstilling af basisk substituerede cyclohexanforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK96175C (da) Fremgangsmåde til fremstilling af 9,10-dihyfroantracenderivater eller syreadditionssalte heraf.
DK93354C (da) Fremgangsmåde til fremstilling af 1,2'-chlor-4'-amino-benzoyl- 4-2',6'-dichlor-benzyl-piperazin eller syreadditionssalte deraf.
DK96121C (da) Fremgangsmåde til fremstilling af phenthiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK96120C (da) Fremgangsmåde til fremstilling af phenthiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK95368C (da) Fremgangsmåde til fremstilling af phenthiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.
DK95324C (da) Fremgangsmåde til fremstilling af phenthiazinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser deraf.